Nobody would argue that the 2005 decision extending the committee's legislative powers to include the National Immunisation Program has made it easier for vaccine makers. If you give them more powers, they will use them to impose more hurdles and test the limits, including with their minister.
Who are 'legislated conditional listings' designed to limit, the industry or the minister?
May 11, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
Taylor confirms Anne Ruston will retain health portfolio in opposition reshuffle
February 17, 2026 - - Latest News -
Minister confirms PBS listing for new cystic fibrosis therapy and funded access to other medicines
February 16, 2026 - - Latest News -
Director pay rises across ASX healthcare sector, but gender balance remains uneven
February 16, 2026 - - Latest News -
Life sciences sector unites to advance women’s leadership at landmark 2026 events
February 16, 2026 - - Latest News -
New imaging agent shows stronger detection of recurrent prostate cancer in head-to-head trial
February 16, 2026 - - Australian Biotech -
Medibank funding expansion signals momentum for Emyria’s mental health model
February 16, 2026 - - Latest News -
IMF pours cold water on fears of US pharmaceutical tariffs as pressures shift to care spending
February 16, 2026 - - Latest News

